Ironwood Pharmaceuticals Hits New 12-Month High at $15.95 (IRWD)
Ironwood Pharmaceuticals (NASDAQ:IRWD) shares hit a new 52-week high during mid-day trading on Wednesday , AmericanBankingNews.com reports. The stock traded as high as $15.95 and last traded at $15.17, with a volume of 583,671 shares traded. The stock had previously closed at $15.18.
IRWD has been the subject of a number of recent research reports. Analysts at Furey Research Partners initiated coverage on shares of Ironwood Pharmaceuticals in a research note on Wednesday, July 9th. They set a “buy” rating and a $20.00 price target on the stock. Separately, analysts at Mizuho raised their price target on shares of Ironwood Pharmaceuticals from $17.00 to $19.00 in a research note on Wednesday, June 25th. They now have a “buy” rating on the stock. Finally, analysts at WallachBeth Capital initiated coverage on shares of Ironwood Pharmaceuticals in a research note on Wednesday, June 18th. They set a “hold” rating and a $16.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and seven have assigned a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $15.30.
The stock’s 50-day moving average is $14.82 and its 200-day moving average is $13.4. The company’s market cap is $2.101 billion.
Ironwood Pharmaceuticals, Inc is a pharmaceutical company, which discovers, develops and intends to commercialize differentiated medicines.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.